Bristol-Myers Squibb BMY Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's intangibles (net)?
- Bristol-Myers Squibb (BMY) reported intangibles (net) of $17.39B in Q2 2026.
- How has Bristol-Myers Squibb's intangibles (net) changed year-over-year?
- Bristol-Myers Squibb's intangibles (net) decreased by 18.7% year-over-year, from $21.38B to $17.39B.
- What is the long-term trend for Bristol-Myers Squibb's intangibles (net)?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's intangibles (net) has grown at a -18.5% compound annual growth rate (CAGR), from $53.24B to $19.1B.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.